Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype
Irit Tirosh(Boston Children's Hospital), Yu Nee Lee(Tel Aviv University), Waleed Al–Herz(Kuwait University), Francesco Frugoni(Boston Children's Hospital), Luigi D. Notarangelo(National Institutes of Health), Jolán E. Walter(Massachusetts General Hospital), Eric J. Allenspach(Center for Infectious Disease Research), Francesca A. Ververs(Boston Children's Hospital), Mirjam van der Burg(Leiden University Medical Center), Lenora M. Noroski(Baylor College of Medicine), Yu Zhang(National Institute of Allergy and Infectious Diseases), Siobhan O. Burns(Royal Free London NHS Foundation Trust), Yasuhiro Yamazaki(National Institutes of Health), Andrew R. Gennery(Hôpital Necker-Enfants Malades)
Cited by 45
Related Papers
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
Immune dysregulation in human subjects with heterozygous germline mutations in <i>CTLA4</i>
|Science|2014|844
MHC class II–dependent basophil–CD4+ T cell interactions promote TH2 cytokine–dependent immunity
|Nature Immunology|2009|590